These innovative treatments , including Semaglutide , belong to a category of drugs called GLP-1 mimics . Originally approved for controlling type 2 diabetes , they function by encouraging the body to release adequate the hormone insulin and limiting excessive sugar levels. Beyond diabetes, their capacity to promote slimming has resulted to increas